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OBJECTIVES The goal of this study was to determine whether wall stress at rest and during stress could
explain the influence of left ventricular (LV) morphology on the accuracy of dobutamine
stress echocardiography (DSE).
BACKGROUND The sensitivity of DSE appears to be reduced in patients with concentric remodeling, but the
cause of this finding is unclear.
METHODS We studied 161 patients without resting wall motion abnormalities who underwent DSE and
coronary angiography. Patients were classified into four groups according to relative wall
thickness (normal 0.45) and LV mass (normal 131 g/m2 in men and 100 g/m2 in
women): normal geometry, concentric remodeling, concentric hypertrophy, and eccentric
hypertrophy. Significant coronary artery disease was defined as 50% stenosis. Circumfer-
ential (cESS) and meridional end-systolic wall stress (mESS) were calculated at rest and peak
DSE.
RESULTS Both false-negative and false-positive results for DSE were present in 35 patients (22%). The
accuracy of DSE in patients with concentric remodeling (61%) was lower than that in patients
with normal geometry (85%, p  0.05) or concentric hypertrophy (86%, p  0.05), but the
accuracy with eccentric hypertrophy (64%, p  0.05) was lower than with concentric
hypertrophy. Patients in lowest quartile of cESS and mESS at peak had significantly lower
sensitivity and accuracy than those in the highest quartile. A reduced cESS at peak (p 
0.012), presence of concentric remodeling (p 0.044), and eccentric hypertrophy (p 0.012)
were significant predictors of both false-negative and false-positive results for DSE.
CONCLUSIONS The accuracy of DSE is influenced by the LV geometric pattern and peak wall stress. (J Am
Coll Cardiol 2002;40:1311–9) © 2002 by the American College of Cardiology Foundation
Dobutamine stress echocardiography (DSE) has a high
sensitivity (70% to 96%) and specificity (66% to 100%) (1)
for the detection of coronary artery disease (CAD), even in
patients with left ventricular (LV) hypertrophy (1,2). How-
ever, despite technical advances, there remain a significant
number of DSE examinations with false-negative and
false-positive results. Previous studies (1–3) have indicated a
number of potential sources of false-negative and false-
positive results. A recent study by Smart et al. (4) showed
that the sensitivity of DSE is reduced in the subset of
patients with LV hypertrophy who have concentric remod-
eling. We sought to confirm the influence of LV geometry
on the accuracy of DSE and to determine the influence of
wall stress on accuracy.
METHODS
Patient population. Between September 1998 and April
2000, dobutamine stress echocardiography (DSE) was per-
formed in 1,031 patients with known or suspected CAD.
Of these patients, 447 with abnormal LV function (LV
ejection fraction  50%) were excluded, as were 361
patients who did not undergo coronary angiography. Of the
223 patients with DSE and coronary angiography within six
months, without an intervening event, 34 with LV wall
motion asynergy at rest, 13 who had poor image quality,
seven with asymmetrical LV hypertrophy (septal to poste-
rior wall thickness ratio  1.3), five who had pacemaker
rhythm, and three with severe valvular disease were ex-
cluded. The remaining 161 patients (105 men; mean age 61
 11 years), who were considered unlikely to have myocar-
dial infarction, were enrolled in this study.
All patients had a complete clinical history taken at
recruitment. Hypertension was defined by a systolic blood
pressure (BP) 140 mm Hg, a diastolic BP 90 mm Hg,
or by antihypertensive drug therapy. Hypercholesterolemia
was defined as total serum cholesterol 200 mg/dl or the
use of lipid-lowering therapy. Diabetes mellitus was defined
as fasting blood glucose 126 mg/dl or treatment with
hypoglycemic drugs and/or insulin.
DSE. Dobutamine stress echocardiography was performed
using a standard protocol (1,2) in all patients after obtaining
informed consent. Before the infusion was begun, a resting
electrocardiogram and echocardiogram were obtained in the
left lateral decubitus position using commercially available
ultrasound equipment (Vingmed system FiVe, General
Electric Vingmed, Milwaukee, Wisconsin). Dobutamine
was administered intravenously with an infusion pump at 5
g/kg/min, and the dosage was increased every 3 min to 10,
20, 30, and, finally, 40 g/kg/min. If 85% of the age-
predicted maximal heart rate (HR) was not achieved, 0.25
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mg of atropine was given every minute up to a maximum of
2 mg or until the target HR was achieved. Cardiac rhythm
was monitored throughout the DSE, and 12-lead electro-
cardiogram and BP measurements were obtained at rest and
the end of each stage. Standard end points were used,
including conclusion of the protocol, development of severe
ischemia (either severe angina or severe impairment of LV
function), severe ventricular arrhythmia, hypertension (sys-
tolic BP 240 mm Hg), symptomatic hypotension, or
intolerable side effects.
The LV was divided into 16 segments as recommended
by the American Society of Echocardiography (5), and each
segment was scored as normal, mild hypokinetic, severe
hypokinetic, akinetic, or dyskinetic. All echocardiograms
were interpreted by comparison of rest and stress images in
quad-screen format by an experienced observer who was
unaware of the patient’s treatment and outcome. Segments
without any deterioration induced by DSE were character-
ized as normal. Ischemia was identified in the presence of a
new wall motion abnormality during the DSE.
Echocardiographic analysis. The septal and posterior wall
thickness at end-diastole and end-systole and LV end-
diastolic and end-systolic diameters were determined from
M-mode or B-mode echocardiograms. Left ventricular and
midwall fractional shortening at rest and peak stress were
calculated using previously reported formulae (6). Relative
wall thickness (RWT) was calculated as the ratio of 2 
posterior wall thickness at end-diastole/LV end-diastolic
diameter. Left ventricular mass was calculated using the
formula proposed by Devereux et al. (7) and normalized for
body surface area (LV mass index, g/m2). Increased RWT
was defined as 0.45, and increased LV mass index was
defined as 131 g/m2 for men and 100 g/m2 for women
(8). The LV geometric pattern was divided into four groups
of normal geometry, concentric remodeling, concentric
hypertrophy, and eccentric hypertrophy, according to RWT
and LV mass index (9) (Fig. 1).
Circumferential end-systolic wall stress (cESS) at rest and
peak stress was calculated as previously described (10):
cESS  Systolic BP  a2 1  b2/c2  1/b2 a2
where a  (LV end-systolic dimension/2), b  (LV
end-systolic dimension/2)  (posterior wall thickness at
end-systole), c  (LV end-systolic dimension/2)  (poste-
rior wall thickness at end-systole/2).
Meridional end-systolic wall stress (mESS) at rest and
peak stress was calculated according to previous studies
(4,11):
mESS  Systolic BP  2a 1/4h1  h/2a
where h  posterior wall thickness at end-systole and a was
as defined above. The end-systolic wall stress both at rest
and stress were divided into quartiles for analyzing the
relationship between the accuracy of DSE and the end-
systolic wall stress.
Acquisition and analysis of tissue Doppler data. Gray
scale images were obtained at rest, with frame rates between
80 and 120 frames/s depending on the sector width, and
saved in raw data (pre-scan-converted) format. Digital storage
of single cardiac cycle loops triggered to the QRS complex was
saved to magneto optical disk (EDM-2300B, Sony Electronic
Inc., Tochigi, Japan) and analyzed using commercial software
(Echopac 6.1, General Electric Vingmed, Milwaukee, Wis-
consin) by an expert reader blinded to the clinical profile and
visual wall motion analysis of the patients.
Abbreviations and Acronyms
BP  blood pressure
CAD  coronary artery disease
cESS  circumferential end-systolic wall stress
DSE  dobutamine stress echocardiography
HR  heart rate
LV  left ventricle/ventricular
mESS  meridional end-systolic wall stress
RWT  relative wall thickness
Figure 1. The left ventricular (LV) geometric pattern, classified according to relative wall thickness and LV mass index. CH  concentric hypertrophy;
CR  concentric remodeling; EH  eccentric hypertrophy; LVMI  left ventricular mass index; N  normal geometry; RWT  relative wall thickness.
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Color tissue Doppler images from apical four-, two-
chamber, and long-axis views were recorded digitally in the
same way as the gray scale images.
Coronary angiography. Quantitative coronary angiogra-
phy (Phillips Medical Imaging, Best, the Netherlands) was
performed within six months of DSE (mean 1.7  2.1
months) by an experienced angiographer who was blinded
to the echocardiographic data. Significant CAD was defined
as 50% luminal diameter stenosis in 1 major coronary
artery.
Statistical analysis. All data are expressed as mean  SD
or frequency in percent. Differences between two groups of
continuous variables were assessed by unpaired Student t
test, and comparison among multiple groups was performed
by analysis of variance with the Scheffe` post-hoc test.
Categorical variables were analyzed with the chi-square test,
and the Fisher exact test was used when appropriate.
Patients with CAD were classified into subgroups with
true-positive (abnormal DSE and coronary angiography)
and false-negative (normal DSE and abnormal coronary
angiography) results. Sensitivity was calculated as the per-
cent of patients with CAD showing true-positive findings
on DSE. Patients without significant CAD were similarly
classified into groups with true-negative or false-positive
results. Specificity was calculated as the percent of patients
without significant CAD who had true-negative findings on
DSE. Accuracy was calculated as the portion of patients
with and without angiographic evidence of CAD who were
correctly identified by DSE. Sensitivity, specificity, and
accuracy of DSE were also individually calculated at these
different quartiles of wall stress parameters. Chi-square
analysis or a Fisher exact test was used to compare the
sensitivity, specificity, and accuracy in each quartile. Linear
regression analysis was used to identify the correlation
between LV fractional shortening and cESS and mESS at
rest or peak. To determine the predictors of the lower
accuracy of DSE, we divided into two groups with and
without both false-negative and false-positive results for
DSE. Multivariate analysis was performed to determine the
independent predictors of both false-negative and false-
positive results for DSE using stepwise logistic regression
(SPSS version 9.0, SPSS Inc., Chicago, Illinois). Variables
with a p value 0.10 (presence of concentric remodeling
and eccentric hypertrophy, single-vessel left circumferential
disease, cESS at peak, and mESS at peak) were entered into
the multivariate model. All results were considered statisti-
cally significant when the p value was 0.05.
RESULTS
Patient characteristics. In the entire population, hyperten-
sion was documented in 73 patients, diabetes mellitus in 18,
and hypercholesterolemia in 63. A number of patients were
taking medical therapy; 63 were treated with beta-blockers,
29 with calcium antagonists, and 57 with nitrates.
The mean peak dose of dobutamine was 37  7 g/kg/
min. Atropine was used in 82 patients (51%). The resting
HR, systolic BP, and rate-pressure product were 69  12
beats/min, 138  24 mm Hg, and 9,698  2,758 mm
Hg/min, and respective values at peak stress were 132  19
beats/min, 170  27 mm Hg, and 22,667  4,829 mm
Hg/min. A total of 114 patients (71%) reached the target
HR (85% of age-predicted maximal HR). Submaximal
tests (defined by termination at less than target HR)
occurred despite maximum doses in 25 patients; premature
termination of the protocol occurred because of severe
ischemia in 12, hypertension in three, symptomatic hypo-
tension in two, complex ventricular premature contractions
in two, nausea in two, and anxiety in one.
Coronary angiography detected significant CAD in 107
patients (66%), 61 of whom had multivessel disease. Of
those with single-vessel disease, 17 had left anterior de-
scending disease, 10 had left circumflex disease, and 19 had
right CAD.
Clinical characteristics and LV geometric pattern. The
clinical characteristics of patients grouped according to the
LV geometric pattern are summarized in Table 1. Of the
enrolled patients, 29% had normal geometry, 14% had
concentric remodeling, 39% had concentric hypertrophy,
and 17% had eccentric hypertrophy. There were no signif-
icant differences among LV geometric groups with regard to
age, gender, body mass index, HR, BP, incidence of risk
factors, and medications. The prevalence of CAD was also
similar in each group.
Echocardiographic parameters and LV geometric pat-
tern. By definition, LV mass index was increased in the
groups with concentric and eccentric hypertrophy, whereas
RWT was increased in the two groups with concentric LV
geometric patterns (Table 2). Left ventricular and midwall
fractional shortening were significantly greater in patients
with normal geometry than in patients with eccentric
hypertrophy. Although cESS and mESS at peak stress were
similar among these groups, cESS and mESS at rest were
greatest in patients with eccentric hypertrophy.
Detection of CAD from DSE. There were 63 patients
with normal DSE and 98 patients with ischemia during the
DSE. The sensitivity, specificity, and accuracy of wall
motion abnormalities for detecting CAD were 79% (85 of
107), 76% (41 of 54), and 78% (126 of 161), respectively.
Sensitivity for multivessel disease (82%, 50 of 61) was
comparable with that for single-vessel disease (76%, 35 of
46, p  0.62). In single-vessel disease, sensitivity for
patients with 50% to 69% stenosis (58%, 11 of 19) was less
(but not significantly so) than that with 70% stenosis
(77%, 24 of 31, p  0.25). Sensitivity was 95% (18 of 19) in
single-vessel right CAD, 71% (12 of 17) in single-vessel left
anterior descending disease, but only 50% (5 of 10, p 0.05
vs. single-vessel right CAD) in single-vessel left circumflex
disease. The positive predictive value of patients with wall
motion abnormalities at single basal inferior segment was
71% (5 of 7).
Table 3 summarizes the likely causes of the 13 false-
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positive results for DSE; five had intermediate coronary
stenosis, and two had wall motion abnormalities at single
basal inferior segment. Generally, wall stress did not explain
the false-positive results. In 22 patients with false-negative
results for DSE, 11 had single-vessel disease, eight were
treated with beta-blockers, and six had submaximal tests of
DSE (Table 4). Several patients in whom the false-negative
result was not otherwise explained showed low levels of wall
stress.
Effects of echocardiographic parameters on accuracy of
DSE. The LV mass index did not influence the accuracy of
DSE for detection of CAD. The sensitivity (79% vs. 80%,
p  0.84, respectively) and specificity (79% vs. 71%, p 
0.77, respectively) were similar in groups with and without
increased LV mass index. The accuracy of DSE for detec-
tion of CAD was markedly reduced by concentric remod-
eling (61%), compared with both normal geometry (85%,
p 0.05) and concentric hypertrophy (96%, p 0.05). The
accuracy of DSE in patients with eccentric hypertrophy was
also significantly reduced in comparison with that of con-
centric hypertrophy (Fig. 2).
With the exception of cESS at peak (104  31 kdyne/
cm2 vs. 124  46 kdyne/cm2, p  0.02, respectively) and
mESS at peak (35  12 kdyne/cm2 vs. 42  17 kdyne/cm2,
p  0.03, respectively), no statistically significant difference,
including gender, beta-blockers, left bundle branch block,
and single-vessel disease, was found between the group with
and without both false-positive and false-negative results for
DSE. Single-vessel left circumflex disease, concentric re-
modeling, and eccentric hypertrophy tended to be more
frequent in the group with both false-positive and false-
negative results.
In false-negative studies, peak cESS (103  29 vs. 122 
38 kdyne/cm2, p  0.06) and peak mESS (36  11 vs. 43
 16 kdyne/cm2, p  0.09) tended to be less than those
with true-negative studies. No significant difference of cESS
and mESS at either rest or peak stress was found between
false-positive and true-positive studies for DSE.
Table 1. Clinical Characteristics of Study Patients Grouped According to Left Ventricular
Geometric Pattern
Normal
Geometry
(n  47)
Concentric
Remodeling
(n  23)
Concentric
Hypertrophy
(n  63)
Eccentric
Hypertrophy
(n  28)
p
Value
Age (yrs) 59  11 65  13 60  11 60  10 0.18
Male 31 (66%) 14 (61%) 43 (68%) 17 (61%) 0.99
Body mass index (kg/m2) 27.1  5.1 28.2  4.7 28.5  4.7 28.2  4.8 0.50
Rest HR (beats/min) 65  13 72  12 71  12 71  15 0.08
Peak HR (beats/min) 132  20 129  23 133  15 132  24 0.78
Rest systolic BP (mm Hg) 133  23 146  24 137  25 142  21 0.20
Peak systolic BP (mm Hg) 173  23 171  26 170  30 166  30 0.83
Submaximal test 16 (34%) 5 (22%) 19 (43%) 7 (33%) 0.96
Coronary artery bypass graft 3 (6%) 2 (9%) 6 (10%) 1 (4%) 0.99
Left bundle-branch block 2 (4%) 1 (4%) 1 (2%) 0 0.82
Single-vessel disease 16 (34%) 6 (26%) 18 (29%) 6 (21%) 0.84
Multivessel disease 18 (38%) 9 (39%) 20 (32%) 14 (50%) 0.58
Data are presented as mean value  SD or number (%) of patients.
BP  blood pressure; HR  heat rate.
Table 2. Echocardiographic Parameters of Study Patients Grouped According to Left Ventricular Geometric Pattern
Normal
Geometry
(n  47)
Concentric
Remodeling
(n  23)
Concentric
Hypertrophy
(n  63)
Eccentric
Hypertrophy
(n  28)
p
Value
Septal wall thickness (mm) 9.5  1.1 10.8  1.2* 12.8  2.0*§ 10.6  1.3* 0.001
Posterior wall thickness (mm) 9.2  1.1 11.0  1.0* 12.5  1.3*†§ 10.6  0.9* 0.001
Relative wall thickness 0.37  0.05 0.52  0.06*§ 0.51  0.07*§ 0.39  0.04 0.001
LV mass (g) 192  40 184  34 297  77*† 277  54*† 0.001
LV mass index (g/m2) 100  18 102  17 158  37*† 141  19*† 0.001
LV end-diastolic diameter (mm) 49.6  3.9 42.4  3.3*‡ 49.3  4.5 55.0  3.6*†‡ 0.001
LV fractional shortening at rest (%) 37.7  7.5§ 36.7  4.5 35.7  6.6 32.1  7.2 0.01
LV fractional shortening at peak (%) 37.9  6.3 35.9  6.6 37.5  7.6 36.9  5.8 0.41
Midwall fractional shortening (%) 22.7  4.5§ 20.5  3.0 20.1  4.9 18.8  6.7 0.01
Circumferential ESS at rest (kdyne/cm2) 130  41 115  32 114  46 160  46*†‡ 0.001
Circumferential ESS at peak (kdyne/cm2) 131  54 112  31 111  40 125  40 0.11
Meridional ESS at rest (kdyne/cm2) 48  17 40  12 41  19 60  19*†‡ 0.001
Meridional ESS at peak (kdyne/cm2) 44  19 38  12 38  16 44  16 0.17
Data are presented as mean value  SD or number (%) of patients. *p  0.05 vs. normal geometry; †p  0.05 vs. concentric remodeling; ‡p  0.05 vs. concentric hypertrophy;
§p  0.05 vs. eccentric hypertrophy.
ESS  end-systolic stress; LV  left ventricular.
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The relationship between cESS and mESS at peak stress
and accuracy of DSE is summarized in Figures 3 and 4.
Patients in the highest quartile of cESS had significantly
higher sensitivity and accuracy than those in the lowest
quartile (96% vs. 71%, p 0.05 and 91% vs. 68%, p 0.05,
respectively) and higher sensitivity than those in the third
quartile (65%, p  0.05). Similarly, patients in the highest
quartile of mESS at peak had significantly higher sensitivity
and accuracy than those in the lowest quartile (96% vs. 71%,
p  0.05 and 91% vs. 65%, p  0.05, respectively).
Sensitivity, specificity, and accuracy of cESS and mESS at
rest were comparable among each quartile.
Relationship between LV fractional shortening and pa-
rameters of wall stress. At rest, the inverse relationship of
LV fractional shortening to parameters of wall stress was
significant for both cESS (r  	0.59, p  0.0001) and
mESS (r  	0.62, p  0.0001). Similarly, LV fractional
shortening at peak was inversely related to both cESS (r 
	0.54, p  0.0001) at peak (Fig. 5, left) and mESS (r 
	0.57, p  0.0001) at peak (Fig. 5, right).
Predictors of both false-positive and false-negative re-
sults for DSE. Multivariate logistic regression analysis
demonstrated that cESS at peak (odds ratio, 6.4; 95%
confidence interval, 0.97 to 0.99, p  0.012), presence of
concentric remodeling (odds ratio, 4.1; 95% confidence
interval, 1.01 to 9.62, p  0.044), and presence of eccentric
hypertrophy (odds ratio, 6.4; 95% confidence interval, 1.35
to 12.88, p  0.012) were the most significant predictors of
both false-positive and false-negative results for DSE.
DISCUSSION
The major findings of this study are that reduced wall stress
at peak and LV geometric pattern influence the accuracy of
DSE. This reduction of wall stress at peak stress may have
a greater impact on the false-negative results than on the
false-positive results of DSE.
LV wall stress and accuracy of DSE. Dobutamine stress
echocardiography in patients with both increased wall
thickness and normal LV mass index (i.e., concentric
remodeling) has recently been reported to have a lower
sensitivity than observed in other groups (4). The authors
postulated a relationship between low sensitivity of DSE
and low systolic wall stress at rest, based on the lower
metabolic requirements of myocardium exposed to lower
wall stress. However, the determinative measurement in this
regard would be systolic wall stress at peak stress, which, in
our study, was independently associated with the accuracy of
DSE. Furthermore, we found a close inverse relationship
between systolic wall stress and LV systolic function not
only at rest, which was observed in a previous study (12), but
also at peak stress. Thus, patients with low systolic wall
stress at peak dobutamine have a hyperdynamic response
during DSE. In this situation, the detection of a new wall
motion abnormality may be difficult because of tethering
effects from adjacent hyperdynamic segments. The lowerTa
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Table 4. Clinical Echocardiographic, and Hemodynamic Features of 22 Patients With False-Negative Results for Dobutamine Stress Echocardiography
Age
(yrs) Gender
Peak Heart Rate
(beats/min)
Submaximal
Test
Beta-
Blockers
Single-Vessel
Disease
LV Geometric
Pattern
Circumferential ESS (kdyne/cm2) Meridional ESS (kdyne/cm2)
Rest Quartile Peak Quartile Rest Quartile Peak Quartile
1 59 F 140  N 132 3rd 134 3rd 26 1st 50 3rd
2 56 M 128   N 145 4th 131 3rd 66 4th 50 3rd
3 67 M 130 LAD N 91 1st 156 4th 35 2nd 28 1st
4 55 F 141  LAD N 133 3rd 93 2nd 50 3rd 31 2nd
5 43 M 150 N 74 1st 98 2nd 26 1st 30 1st
6 69 M 131 LCX CR 101 2nd 52 1st 39 2nd 17 1st
7 59 M 145 CR 89 1st 127 3rd 34 2nd 44 3rd
8 75 F 122 LAD CR 79 1st 115 2nd 27 1st 47 3rd
9 37 M 159 CR 139 3rd 117 3rd 54 4th 45 3rd
10 51 F 82  RCA CR
11 48 M 146 LCX CH 114 2nd 56 1st 42 2nd 18 1st
12 42 M 139  CH
13 79 M 134 LAD CH 124 3rd 67 1st 43 3rd 25 1st
14 74 M 129 LCX CH 86 1st 62 1st 30 1st 20 1st
15 53 M 141 CH 82 1st 119 3rd 26 1st 43 3rd
16 68 M 141  EH 127 3rd 132 3rd 50 3rd 53 4th
17 60 M 97   LAD EH 140 3rd 99 2nd 54 4th 36 2nd
18 51 F 75   LCX EH 140 3rd 120 3rd 48 3rd 35 2nd
19 63 M 135  EH 159 4th 78 1st 68 4th 32 2nd
20 64 F 129 LCX EH 250 4th 126 3rd 90 4th 46 3rd
21 62 M 60   EH 164 4th 64 4th
22 75 F 141 EH 168 3rd 87 1st 63 3rd 33 2nd
Abbreviations as in Tables 2 and 3. The quartiles of each parameter of wall stress as in Table 3.
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recorded sensitivity may, therefore, reflect difficulties in the
recognition of inducible wall motion abnormalities due to
LV cavity obliteration (13). The lower sensitivity in the
setting of the lower wall stress may also be explained by the
induction of less ischemia due to lower myocardial oxygen
consumption. Indeed, the parallel relationship between LV
wall stress and myocardial oxygen consumption has been
reported in patients with hypertension and dilated cardio-
myopathy (14,15). Carbon-11 acetate positron emission
tomography (16) has also shown that myocardial oxygen
consumption correlates closely with the rate-pressure prod-
uct during dobutamine stress.
On the other hand, it may be difficult to explain how
lower wall stress contributes to lower specificity of DSE
(i.e., false-positive results). It is possible that angiography
was performed more often in those with dilated ventricles
and wall motion abnormalities. This referral bias may have
increased the number of false-positive eccentric hypertrophy
patients and may be a possible explanation of the lower
specificity of DSE in this group. Small sample sizes used for
Figure 2. Sensitivity (left), specificity (center), and accuracy (right) of dobutamine stress echocardiography, according to the left ventricular geometric
pattern. White bars  normal geometry (N); light gray bars  concentric remodeling (CR); dark gray bars  concentric hypertrophy (CH); black bars
 eccentric hypertrophy (EH).
Figure 3. Sensitivity (left), specificity (center), and accuracy (right) of dobutamine stress echocardiography, according to quartiles of circumferential
end-systolic wall stress (cESS) at peak (1st lowest quartile [90 kdyne/cm2], 2nd 2nd lowest quartile [90 to 115 kdyne/cm2], 3rd 3rd lowest quartile
[116 to 144 kdyne/cm2], 4th  highest quartile [145 kdyne/cm2]).
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calculation of specificity in the concentric remodeling and
eccentric hypertrophy groups may be another explanation
for the apparent lower specificity in these groups. Further,
wall stress at both rest and peak showed no significant
difference between false-positive and true-positive studies.
Thus, lower wall stress at peak dobutamine may have a
lesser impact on the false-positive results for DSE.
LV geometry and accuracy of DSE. In our study, not only
concentric remodeling, but also eccentric hypertrophy was
associated with lower accuracy of DSE. The latter finding
appears consistent with previous studies (17,18) that reported a
lower specificity of dobutamine or exercise stress echocardiog-
raphy in patients with dilated LV and reduced LV systolic
function (e.g., dilated cardiomyopathy and severe aortic regur-
gitation). These conditions have a common feature of func-
tional and structural abnormalities of the myocardium, sug-
gesting that latent myocardial abnormalities (e.g., fibrosis)
could influence the appearance of regional wall motion abnor-
malities with stress test. These abnormalities may be detected
non-invasively with tissue velocity imaging (19).
A number of factors have been associated with false-
negative and false-positive findings at DSE (1–3), but these
Figure 4. Sensitivity (left), specificity (center), and accuracy (right) of dobutamine stress echocardiography, according to quartiles of meridional
end-systolic wall stress (mESS) at peak (1st lowest quartile [30 kdyne/cm2], 2nd 2nd lowest quartile [30 to 38 kdyne/cm2], 3rd 3rd lowest quartile
[39 to 49 kdyne/cm2], 4th  highest quartile [50 kdyne/cm2]).
Figure 5. Correlation of left ventricular fractional shortening at peak with circumferential end-systolic wall stress at peak (cESS) (left) and meridional
end-systolic wall stress (mESS) at peak (right).
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did not differ among the groups with different LV morphol-
ogies. Other possibilities, such as underestimation of coro-
nary stenoses or coronary vasospasm during DSE (4,20),
may have contributed to the findings, as LV hypertrophy is
associated with reduced coronary flow reserve and increased
intima-media thickness (21,22). Thus, although LV size
and geometry appear to be related to the accuracy of DSE,
the contribution of other factors remains unclear.
Study limitations. We could not exclude the possibility
that several factors not assessed in this study, such as
decreased coronary flow reserve and ischemia due to micro-
vascular coronary disease, contributed to the results of DSE.
Clinical implications. The results of this study clarify the
close relationship between the accuracy of DSE—especially
with regard to sensitivity—and end-systolic wall stress at
peak stress. Hyperdynamic responses that are related to this
reduced end-systolic wall stress should be taken into con-
sideration in the interpretation of DSE. From a diagnostic
standpoint, wall stress at peak dobutamine and LV geomet-
ric pattern appear to influence the accuracy of DSE.
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wick, University of Queensland, Department of Medicine, Prin-
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